GENERAL ANXIETY DISORDER
Clinical trials for GENERAL ANXIETY DISORDER explained in plain language.
Never miss a new study
Get alerted when new GENERAL ANXIETY DISORDER trials appear
Sign up with your email to follow new studies for GENERAL ANXIETY DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a headset calm anxious teens without pills?
Symptom relief CompletedThis study tests whether a headset that delivers tiny electrical pulses to nerves behind the ear can reduce anxiety in teens aged 12-17 with Generalized Anxiety Disorder. Sixty participants will use either the active device or a sham (fake) device for 30 minutes a day, 5 days a w…
Matched conditions: GENERAL ANXIETY DISORDER
Phase: NA • Sponsor: Neurovalens Ltd. • Aim: Symptom relief
Last updated Jul 02, 2026 05:00 UTC
-
New anxiety drug shows promise in early trial
Symptom relief CompletedThis study tested a new drug called ENX-102 in 38 adults with generalized anxiety disorder. Participants received either a low, mid, or high dose of ENX-102 or a placebo for six weeks. The goal was to check safety and find the best dose. The trial is now complete.
Matched conditions: GENERAL ANXIETY DISORDER
Phase: PHASE2 • Sponsor: Engrail Therapeutics INC • Aim: Symptom relief
Last updated Jun 26, 2026 18:21 UTC